Journal Article Ppublish
PubMed: 40042819 DOI: 10.1001/jamadermatol.2024.6654
Long-Term Efficacy and Safety of Rituximab in Patients With Pemphigus Foliaceus Compared With Pemphigus Vulgaris.
JAMA Dermatol 161(4):444-446
Authors: Billal Tedbirt, Estelle Houivet, Maud Maho-Vaillant, Marie-Laure Golinski, Sébastien Calbo, Catherine Prost-Squarcioni, Bruno Labeille, Catherine Picard-Dahan, Guillaume Chaby, Marie-Aleth Richard, Emmanuelle Tancrède-Bohin, Sophie Duvert-Lehembre, Emmanuel Delaporte, Philippe Bernard, Frédéric Caux, Marina Alexandre, Philippe Musette, Saskia Ingen-Housz-Oro, Pierre Vabres, Gaëlle Quereux, Alain Dupuy, Sébastien Debarbieux, Martine Avenel-Audran, Michel D'Incan, Christophe Bédane, Nathalie Bénéton, Denis Jullien, Nicolas Dupin, Laurent Misery, Laurent Machet, Marie Beylot-Barry, Olivier Dereure, Bruno Sassolas, Nadège Cordel, Géraldine Jeudy, Jacques Benichou, Vivien Hébert, Pascal Joly
Affiliations
- Department of Dermatology, CHU Rouen, Rouen, France.
- Univ Rouen Normandie, Inserm UMR 1234, Rouen, France.
- Department of Biostatistics and Clinical Research, CHU Rouen, Rouen, France.
- Department of Dermatology, Centre de Référence des Maladies Bulleuses Auto-immunes, Avicenne Hospital, Assistance Publique-Hôpitaux de Paris, University of Paris 13, Bobigny, France.
- Department of Dermatology, University of Saint-Étienne, Saint-Étienne, France.
- Department of Dermatology, Bichat Hospital, University of Paris 10, Paris, France.
- Department of Dermatology, University of Amiens, Amiens, France.
- CEReSS-EA 3279, Research Centrer in Health Services and Quality of Life, Aix Marseille University, Department of Dermatology, Universitary Hospital Timone, Assistance Publique Hôpitaux de Marseille, Marseille, France.
- Department of Dermatology, St Louis Hospital, Paris Cité University, Paris, France.
- Department of Dermatology, CHU Lille, Lille, France.
- Department of Dermatology, CH Dunkerque, Dunkirk, France.
- Department of Dermatology, North Hospital, Marseille University Hospital and Aix Marseille University, Marseille, France.
- Department of Dermatology, University of Reims, Reims, France.
- Department of Dermatology, Assistance Publique-Hôpitaux de Paris, Henri Mondor Hospital, Univ Paris Est Créteil EpiDermE, Créteil, France.
- Department of Dermatology, Dijon University Hospital, Dijon, France.
- Department of Dermatology, CHU Nantes, Nantes University, CIC 1413, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302, Nantes, France.
- Department of Dermatology, University of Rennes, Rennes, France.
- Department of Dermatology, Centre Hospitalier Lyon Sud, Pierre Bénite, Lyon, France.
- Department of Dermatology, University of Angers, Angers, France.
- Department of Dermatology, University of Clermont-Ferrand, Clermont-Ferrand, France.
- Department of Dermatology, University of Limoges, Limoges, France.
- Department of Dermatology, Le Mans General Hospital, Le Mans, France.
- Department of Dermatology, Edouard Herriot Hospital, Lyon Claude Bernard University, Lyon, France.
- Department of Dermatology, Assistance Publique-Hôpitaux de Paris and University of Paris Cité, Paris, France.
- Department of Dermatology, Brest University Hospital, Brest, France.
- Department of Dermatology, Tours University Hospital, Tours, France.
- Department of Dermatology, University of Bordeaux, Bordeaux, France.
- Department of Dermatology, University of Montpellier, Montpellier, France.
- Department of Internal Medicine, Brest University Hospital, Brest, France.
- Department of Dermatology and Clinical Immunology, Guadeloupe University Hospital, Pointe-à-Pitre, and Normandie University, UNIROUEN, IRIB, Inserm U1234, Rouen, France.
- Department of Dermatology, CHU Le Bocage, Dijon, France.
- Department of Biostatistics and Clinical Research, CHU Rouen and Inserm U1018, Université Paris-Saclay and Université de Rouen, Rouen, France.
MeSH
Safety, Skin Diseases, Rituximab, Pemphigus